Next-Generation Sequencing Of Longitudinal Blood Samples May Identify Genetic Mutations Tied To Hyperprogression And Early Death From ICI In Patients With Advanced NSCLC, Research Suggests
October 07, 2020
Cancer Therapy Advisor (10/6, S. Blevins Primeau) reports researchers found in the prospective MAGIC-1 trial that “next-generation sequencing of longitudinal blood samples identified gene alterations associated with hyperprogression and early death from i...